In vivo imaging of cerebral glucose metabolism informs on subacute to chronic post-stroke tissue status – A pilot study combining PET and deuterium metabolic imaging
Anu E Meerwaldt,Milou Straathof,Wija Oosterveld,Caroline L van Heijningen,Mandy MT van Leent,Yohana C Toner,Jazz Munitz,Abraham JP Teunissen,Charlotte C Daemen,Annette van der Toorn,Gerard van Vliet,Geralda AF van Tilborg,Henk M De Feyter,Robin A de Graaf,Elly M Hol,Willem JM Mulder,Rick M Dijkhuizen
DOI: https://doi.org/10.1177/0271678X221148970
2023-01-08
Abstract:Journal of Cerebral Blood Flow &Metabolism, Ahead of Print. Recanalization therapy after acute ischemic stroke enables restoration of cerebral perfusion. However, a significant subset of patients has poor outcome, which may be caused by disruption of cerebral energy metabolism. To assess changes in glucose metabolism subacutely and chronically after recanalization, we applied two complementary imaging techniques, fluorodeoxyglucose (FDG) positron emission tomography (PET) and deuterium (2H) metabolic imaging (DMI), after 60-minute transient middle cerebral artery occlusion (tMCAO) in C57BL/6 mice. Glucose uptake, measured with FDG PET, was reduced at 48 hours after tMCAO and returned to baseline value after 11 days. DMI revealed effective glucose supply as well as elevated lactate production and reduced glutamate/glutamine synthesis in the lesion area at 48 hours post-tMCAO, of which the extent was dependent on stroke severity. A further decrease in oxidative metabolism was evident after 11 days. Immunohistochemistry revealed significant glial activation in and around the lesion, which may play a role in the observed metabolic profiles. Our findings indicate that imaging (altered) active glucose metabolism in and around reperfused stroke lesions can provide substantial information on (secondary) pathophysiological changes in post-ischemic brain tissue.
neurosciences,endocrinology & metabolism,hematology